Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksCELESTIAL
resources
CELESTIAL

Celestial Biolabs Ltd

NSE: CELESTIAL
Sector: Healthcare
Industry: Pharmaceuticals
1.75+0.0 (+0.00%)
16 Oct, 12:00 AM

Annual Reports and Financial Documents

Celestial Biolabs Ltd annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Quarterly Results—————
Conference Calls———————————
Presentations———————————

Corporate Announcements and Regulatory Filings

Celestial Biolabs Ltd BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General30 May 2024
    Intimation Of Board Meeting Cancelled
    Intimation of cancellation of Board meeting which was scheduled on 30.05.2024
  2. Reg.24(A)-Annual Secretarial Compliance29 May 2024
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance report for the year ended 31.03.2024
  3. Board Meeting24 May 2024
    Board Meeting Intimation for Board Meeting Intimation For To Consider The Standalone & Consolidated Audited Financial Results For The Year Ended 31.03.2024
    Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Board Meeting Intimation ....
  4. AGM23 May 2024
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Intimation under Reg.44(3) of SEBI (LODR) 2015- Voting results and Scrutinizer''s report (FY 2022-23) of the Annual General Meeting
  5. AGM23 May 2024
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of AGM for FY 2022-23 as required under Regulation 30 & Schedule III of the SEBI (LODR) Regulations, 2015
  6. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201829 Apr 2024
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance certificate under reg.74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2024
  7. Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition25 Apr 2024
    Compliance Under Reg.40 For The Year Ended 31.03.2024
    Compliance under Reg.40 for the year ended 31.03.2024
  8. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201825 Apr 2024
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance certificate under Reg.74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2023
  9. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201825 Apr 2024
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2023
  10. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201825 Apr 2024
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2023
  11. Book Closure24 Apr 2024
    Intimation Of Book Closure For The Purpose Of Annual General Meeting For FY 2022-23
    To close the Register of members and share transfer books from 21st May, 2024 to 23rd May, 2024 (both days inclusive) for the purpose of Annual General meeting for the FY 2022-23 scheduled ....
  12. Demise23 Apr 2024
    Announcement under Regulation 30 (LODR)-Demise
    Demise of Dr. Devarakonda Chidvilasa Sastri, Non-executive Independent director of the company
  13. Change in Directorate22 Apr 2024
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Appointment of Mr.Dattatreya Rao as Executive Director and Chief Executive Officer of the Company
  14. Change in Management22 Apr 2024
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Mr.Dattatreya Rao as Executive Director & Chief Executive Officer of the company
  15. Appointment of Statutory Auditor/s22 Apr 2024
    Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
    Reappointment of M.Surendra & Associates as statutory auditors of the company
  16. Demise22 Apr 2024
    Announcement under Regulation 30 (LODR)-Demise
    Demise of Dr Devarakonda Chidvilasa Sastri, Non-executive Independent director of the company
  17. Resignation of Director22 Apr 2024
    Announcement under Regulation 30 (LODR)-Resignation of Director
    Resignation of Mr.Amarachinta Padmanabha Rao, Non-executive Independent director of the company
  18. Reg. 7(3) – Compliance Certificate (RTA & Compliance Officer)19 Apr 2024
    Compliance Certificate For The Period Ended 31St March, 2024
    Compliance certificate for the period ended 31st March, 2024
  19. Reg.24(A)-Annual Secretarial Compliance26 Mar 2024
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance report for the year ended 31.03.2023
  20. Board Meeting23 Mar 2024
    Board Meeting Intimation for To Consider The Standalone & Consolidated Audited Financial Results For The Year Ended 31.03.2023 And Standalone & Consolidated Unaudited Financial Results For The Q1, Q2 & Q3 Of FY Year 2023-24
    Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 ,inter alia, to consider and approve Pursuant to Regulation ....

Frequently Asked Questions

Where can I download the annual report of Celestial Biolabs Ltd?
Annual reports of Celestial Biolabs Ltd are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Celestial Biolabs Ltd?
Quarterly earnings results and presentations of Celestial Biolabs Ltd are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Celestial Biolabs Ltd publish earnings call transcripts?
Earnings call transcripts of Celestial Biolabs Ltd, where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Celestial Biolabs Ltd?
Investor presentations and annual day presentations of Celestial Biolabs Ltd are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Celestial Biolabs Ltd?
Corporate announcements and regulatory filings of Celestial Biolabs Ltd as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Celestial Biolabs Ltd?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Celestial Biolabs Ltd are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Celestial Biolabs Ltd?
The ISIN (International Securities Identification Number) of Celestial Biolabs Ltd is INE221I01017. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Celestial Biolabs Ltd listed?
Celestial Biolabs Ltd is listed on NSE and BSE. The NSE symbol is CELESTIAL and the BSE code is -.
Where can I find the shareholding pattern of Celestial Biolabs Ltd?
The quarterly shareholding pattern of Celestial Biolabs Ltd showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Celestial Biolabs Ltd on Sharpely?
Share price data for Celestial Biolabs Ltd is updated as of 16 Oct 2024. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.